Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2025
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO
M M Germani, V Heinemann, D Rossini, et al.
ESMO Open
|
July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
V Daprà, A Gandini, F Schietroma, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study
G Mazzoli, F Nichetti, K Shitara, et al.
ESMO Gastrointestinal Oncology
|
March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study
G Trovato, M Carullo, A Nicastro, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Cell Death & Disease
|
December 5, 2024
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
A Esposito, A Agostini, G Quero, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study
P Andena, G Tine, F Nichetti, et al.
ESMO Open
|
January 5, 2021
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center
G Quero, L Salvatore, C Fiorillo, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2025
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO
M M Germani, V Heinemann, D Rossini, et al.
ESMO Open
|
July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
V Daprà, A Gandini, F Schietroma, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study
G Mazzoli, F Nichetti, K Shitara, et al.
ESMO Gastrointestinal Oncology
|
March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study
G Trovato, M Carullo, A Nicastro, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Cell Death & Disease
|
December 5, 2024
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
A Esposito, A Agostini, G Quero, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study
P Andena, G Tine, F Nichetti, et al.
ESMO Open
|
January 5, 2021
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center
G Quero, L Salvatore, C Fiorillo, et al.
Page
of 15